For several months the US Food and Drug Administration has been exploring new ways to ensure manufacturer compliance during the COVID-19 pandemic. To that end, the agency is assessing via a pilot program whether the use of video is helpful in supporting virtual facility inspections.
“One of the things you always hear is, you never let a good crisis go to waste
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?